Description

▪ Introduction

Bold Med by Pharma Nevis contains Boldenone Undecylenate at 300 mg/mL, an injectable compound studied in laboratory and veterinary contexts for its potential role in supporting red blood cell production, protein retention, and appetite stimulation in models of chronic undernutrition or recovery. Its long-acting ester enables consistent plasma levels, making it suitable for research focused on extended anabolic activity and metabolic stabilization.

Manufactured under GMP-compliant conditions, Bold Med offers clinical-grade sterility and compound consistency for use in regulated laboratory environments.

▪ Product Details

• Active Ingredient: Boldenone Undecylenate

• Dosage Strength: 300 mg/mL

• Form: Injectable solution (intramuscular)

• Brand: Pharma Nevis

• Package Size: 10 mL multi-dose vial

• Intended Use: Laboratory and analytical use only

▪ Pharmacokinetics

Boldenone Undecylenate features a half-life of approximately 14 days, with a slow-release undecylenate ester contributing to prolonged anabolic activity. This property makes it especially suitable for research protocols requiring less frequent administration while maintaining steady-state exposure in long-term studies.

▪ Usage Recommendations

• Route: Intramuscular injection under aseptic conditions

• Suggested Dosing Frequency: Typically once every 10–14 days, as per protocol

• Use Statement: For laboratory and analytical use only by qualified personnel in controlled environments

▪ Disclaimer

This product is intended strictly for laboratory research and analytical use. It is not approved for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with health conditions. All usage must comply with institutional safety standards and local regulatory guidelines.